Skip to main content
. 2020 Jan 11;9(1):200. doi: 10.3390/jcm9010200

Figure 2.

Figure 2

Forest plot of the standardized mean difference (SMD) in nasal nitric oxide (nNO) levels among cases and control subjects. Panel A: nNO in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and healthy controls; Panel B: nNO in patients with chronic rhinosinusitis without nasal polyps (CRSsNP) and healthy controls; Panel C: nNO in CRSwNP and CRSsNP patients.